KONSULT PHARMA SERVICES LIMITEDActive

Company number 09072465Private limited companyIncorporated 2014

Key figures

£11,517+49.5%
Net assets 2024/25
-19.2%
Average annual change 2019/20–2024/25
010 k20 k30 k40 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, KONSULT PHARMA SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
025 k50 k75 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand38,58326,40726,45613,7683,338
Total assets57,96763,57239,77334,36041,639
Total liabilities30,68541,17940,23226,97130,272
Net assets / total equity28,95123,0112437,70311,517
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: KONSULT PHARMA SERVICES LIMITED

Company

KONSULT PHARMA SERVICES LIMITED is a private limited company registered with Companies House under company number 09072465. It was incorporated on 5 Jun 2014. Its status is active. The registered office is in Crowthorne (RG45). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files small company accounts (filleted). Net assets were £11,517, up 49.5% on the previous year. Cash at bank and in hand was £3,338. Total assets were £41,639 and total liabilities £30,272. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 1 Apr 2027. The next confirmation statement is due by 19 Jun 2027.